文献速递临床免疫质量管理与危急值

Abbott Alinity系统内分泌与生育激素检测的儿童参考区间验证

Pediatric reference interval verification for endocrine and fertility hormone assays on the Abbott Alinity system.
PubMed 文献 · Clin Chem Lab Med · 2021-06-30

本研究验证了Abbott Alinity系统上16项免疫分析项目的儿童参考区间,基于100份健康儿童血清样本及与已发表的CALIPER ARCHITECT参考区间比较。13项检测满足≥90%结果落在置信限内的验证标准,游离甲状腺素和催乳素需建立新参考区间,雌二醇在生命早期需特殊考虑。

要点

  • 13/16项Alinity免疫分析项目通过验证,可使用现有CALIPER ARCHITECT儿童参考区间。
  • 游离甲状腺素和催乳素需建立Alinity系统新的儿童参考区间。
  • 雌二醇在生命早期的参考区间需特殊考虑。

核心结论

  • Alinity与ARCHITECT免疫分析结果高度一致,多数项目可直接沿用现有CALIPER儿童参考区间。

研究设计与样本

  • 先评估Alinity免疫分析性能,再用100份健康儿童血清样本分析16项免疫分析,计算落在已发表ARCHITECT参考区间置信限内的结果百分比。
  • 若≥90%结果落在置信限内则依据CLSI指南视为验证通过,否则加测样本并建立新参考区间。

主要发现

  • 16项免疫分析中13项满足验证标准,≥90%健康儿童血清结果落在已发表ARCHITECT置信限内。
  • 游离甲状腺素和催乳素建立了新的Alinity儿童参考区间。
  • 雌二醇在生命早期需要特殊考虑。

关键数值与推荐

  • 验证标准:≥90%的检测结果落在已发表CALIPER ARCHITECT参考区间的置信限内,依据CLSI指南判定验证通过。
  • 未通过验证(<90%结果在置信限内)时,加测样本并建立新的Alinity参考区间。

临床怎么用

  • 使用Abbott Alinity系统的临床实验室可参考本研究结果,对多数免疫分析项目直接采用现有CALIPER儿童参考区间。
  • 对游离甲状腺素、催乳素和雌二醇(尤其生命早期)需注意使用新建立或特殊考虑的参考区间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The Canadian Laboratory Initiative on Pediatric Reference Intervals (CALIPER) has developed an extensive database of reference intervals (RIs) for several biomarkers on various analytical systems. In this study, pediatric RIs were verified for key immunoassays on the Abbott Alinity system based on the analysis of healthy children samples and comparison to comprehensive RIs previously established for Abbott ARCHITECT assays. METHODS: Analytical performance of Alinity immunoassays was first assessed. Subsequently, 100 serum samples from healthy children recruited with informed consent were analyzed for 16 Alinity immunoassays. The percentage of test results falling within published CALIPER ARCHITECT reference and confidence limits was determined. If ≥ 90% of test results fell within the confidence limits, they were considered verified based on CLSI guidelines. If <90% of test results fell within the confidence limits, additional samples were analyzed and new Alinity RIs were established. RESULTS: Of the 16 immunoassays assessed, 13 met the criteria for verification with test results from ≥ 90% of healthy serum samples falling within the published ARCHITECT confidence limits. New CALIPER RIs were established for free thyroxine and prolactin on the Alinity system. Estradiol required special considerations in early life. CONCLUSIONS: Our data demonstrate excellent concordance between ARCHITECT and Alinity immunoassays, as well as the robustness of previously established CALIPER RIs for most immunoassays, eliminating the need for de novo RI studies for most parameters. Availability of pediatric RIs for immunoassays on the Alinity system will assist clinical laboratories using this new platform and contribute to improved clinical decision-making.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Bohn MK, Wilson S, Hall A, et al. Pediatric reference interval verification for endocrine and fertility hormone assays on the Abbott Alinity system. Clin Chem Lab Med. 2021. PMID: 34187103. doi:10.1515/cclm-2021-0337

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。